Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fujii

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Journal of Alzheimer'S Disease : JAD|October 24, 2019
Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative StressKazuki Yokokawa, Naotoshi Iwahara, Shin Hisahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1982
[Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy]T Taguchi, M Izuo, N Ogawa, et al.
Cancer Research|December 11, 1997
MMAC1/PTEN mutations in primary tumor specimens and tumor cell linesD H Teng, R Hu, H Lin, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Journal of Alzheimer'S Disease : JAD|October 24, 2019
Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative StressKazuki Yokokawa, Naotoshi Iwahara, Shin Hisahara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1982
[Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy]T Taguchi, M Izuo, N Ogawa, et al.
Cancer Research|December 11, 1997
MMAC1/PTEN mutations in primary tumor specimens and tumor cell linesD H Teng, R Hu, H Lin, et al.
Pageof 9